RhumbLine Advisers’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,225
| Closed | -$56.5K | – | 4361 |
|
|
2023
Q2 | $56.5K | Buy |
30,225
+21,600
| +250% | +$40.4K | ﹤0.01% | 3655 |
|
|
2023
Q1 | $32K | Buy |
8,625
+535
| +7% | +$1.99K | ﹤0.01% | 2923 |
|
|
2022
Q4 | $25K | Buy |
8,090
+139
| +2% | +$430 | ﹤0.01% | 2977 |
|
|
2022
Q3 | $36K | Buy |
7,951
+558
| +8% | +$2.53K | ﹤0.01% | 3054 |
|
|
2022
Q2 | $195K | Buy |
7,393
+964
| +15% | +$25.4K | ﹤0.01% | 2933 |
|
|
2022
Q1 | $239K | Buy |
6,429
+1,195
| +23% | +$44.4K | ﹤0.01% | 2712 |
|
|
2021
Q4 | $306K | Sell |
5,234
-108
| -2% | -$6.31K | ﹤0.01% | 2696 |
|
|
2021
Q3 | $439K | Buy |
5,342
+587
| +12% | +$48.2K | ﹤0.01% | 2607 |
|
|
2021
Q2 | $449K | Buy |
+4,755
| New | +$449K | ﹤0.01% | 2608 |
|